Rooti Rx ECG Event Recorder vs Zio XT ECG Monitoring System

Direct competitors — feature-level head-to-head below. Comparability 90/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Rooti Labs Ltd.
VS
by iRhythm Technologies

AI Verdict

These tools are direct competitors in the wearable ECG monitoring market, both leveraging AI for cardiac diagnosis. Rooti Rx offers options for single or three-channel ECG recording and rapid report generation within 24 hours, while Zio XT provides up to 14 days of continuous, water-resistant single-lead monitoring with a focus on patient comfort and compliance. The choice between them would depend on the desired monitoring duration, specific ECG lead requirements, and reporting speed.

Choose Rooti Rx ECG Event Recorder if…

Choose Rooti Rx if your clinical workflow prioritizes rapid diagnostic reports, often within 24 hours, and requires medical professionals to have the capability for online ECG review and editing. Its 24-bit high-resolution ECG and optional three-channel recording are particularly beneficial for detailed cardiac analysis, especially when real-time event marking by the patient or caregiver is desired.

View Rooti Rx ECG Event Recorder →

Choose Zio XT ECG Monitoring System if…

Choose Zio XT if you need extended continuous cardiac monitoring for up to 14 days, with a strong emphasis on patient comfort, compliance, and discretion. Its water-resistant, wire-free single-lead biosensor is ideal for patients who require monitoring during normal daily activities, leveraging an FDA-cleared deep-learned AI for accurate and comprehensive arrhythmia detection.

View Zio XT ECG Monitoring System →

When choosing between the Rooti Rx ECG Event Recorder and the Zio XT ECG Monitoring System, physicians should consider their specific needs for monitoring duration, data resolution, and real-time event marking. Both are AI-powered wearable ECG solutions for cardiac monitoring, but they offer distinct advantages. Rooti Rx provides up to 7 days of continuous monitoring with options for single or three-channel ECG, offering 24-bit high-resolution images and mobile telemetry tags for real-time event marking. Its AI-driven interpretation and rapid 24-hour report generation make it suitable for situations requiring detailed ECG data and quick turnaround.

The key practical difference lies in their monitoring capabilities and patient interaction. Rooti Rx emphasizes higher resolution data and real-time event marking through mobile tags, which could be beneficial for complex arrhythmia detection or when precise timing of symptoms is critical. In contrast, the Zio XT system offers extended monitoring for up to 14 days with a single-lead biosensor, prioritizing patient comfort and compliance with its water-resistant, lead-free design and a patient-activated button for symptomatic event logging. Its FDA-cleared deep-learned AI algorithm and cloud-based platform are designed for comprehensive arrhythmia detection over a longer period.

Therefore, a physician prioritizing detailed, high-resolution ECG data, real-time event marking, and faster report generation for up to a week of monitoring might lean towards Rooti Rx. Conversely, for patients requiring longer-term, continuous monitoring (up to 14 days) with an emphasis on comfort, high compliance, and a simplified patient experience, Zio XT would be the more appropriate choice. Both systems offer robust AI analysis and cloud-based platforms, making the decision primarily dependent on the desired monitoring duration, data granularity, and patient-specific needs.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Rooti Rx ECG Event Recorder Zio XT ECG Monitoring System
Pricing Contact for pricing Contact for pricing
Deployment Cloud-based (RootiCare platform on AWS) and device-based Cloud-based (AWS EC2 platform), no on-premise hardware required.
BAA Available Unknown Yes AI-estimated
FDA Status 1 AI-estimated Yes AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio XT ECG Monitoring System

Zio XT prioritizes patient comfort and ease of use with its wire-free, water-resistant design, which contributes to high patient compliance and satisfaction. While Rooti Rx offers a compact device with single or three-channel options, Zio XT's design appears to offer a more seamless and comfortable patient experience for extended wear, including showering and normal daily activities.

Clinical Value

Zio XT ECG Monitoring System

Zio XT offers a longer continuous monitoring duration of up to 14 days, which can increase the diagnostic yield for intermittent arrhythmias compared to Rooti Rx's 7-day limit. Furthermore, Zio XT explicitly combines its FDA-cleared AI with expert review for accurate arrhythmia detection and diagnosis, adding a layer of clinical confidence.

Pricing & Value

Zio XT ECG Monitoring System

Zio XT provides concrete pricing examples for the UK and proposed US Medicare rates, offering significantly more transparency regarding potential costs than Rooti Rx's general 'contact for pricing' statement. This allows healthcare providers to better estimate the financial implications of using the system.

Enterprise Readiness

Zio XT ECG Monitoring System

Zio XT explicitly confirms a Business Associate Agreement (BAA) and states that no on-premise hardware is required, simplifying IT deployment and management for enterprises. While Rooti Rx is cloud-based and HIPAA compliant, its BAA is only stated as 'likely,' and it mentions 'device-based' deployment which could imply more local management.

Innovation

Rooti Rx ECG Event Recorder

Rooti Rx demonstrates innovation through its provision of single or three-channel ECG options, 24-bit high-resolution ECG images, and actigraphy recording, offering a potentially richer and more diverse dataset for diagnosis. It also features mobile telemetry cardiac tags for real-time event marking. While Zio XT features an FDA-cleared deep-learned AI algorithm, Rooti Rx's broader data capture capabilities suggest a different approach to diagnostic depth and flexibility.

Support & Docs

Zio XT ECG Monitoring System

Zio XT provides comprehensive support, including a readily available 24/7 customer care phone number and dedicated Patient Financial Navigators to assist with billing and reimbursement. Rooti Rx offers contact information and FAQs, but does not explicitly detail 24/7 availability or specialized financial support services.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Rooti Rx ECG Event Recorder Zio XT ECG Monitoring System
Device Type/Channels Compact wearable ECG device (single or three-channel options) Wearable single-lead ECG biosensor (Zio biosensor)
Max Recording Duration Up to 7-day ECG and actigraphy recording Continuous ambulatory cardiac monitoring for up to 14 days
AI-driven Analysis AI-driven interpretation and quality assurance checks Proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis
Report Generation Time Fast report generation within 24 hours Not specified
Patient Event Logging Mobile telemetry cardiac tags for real-time event marking Patient-activated button for symptomatic event logging
Water Resistance Not specified Water-resistant design for normal daily activities, including showering

Videos

Demos, reviews, and walkthroughs featuring Rooti Rx ECG Event Recorder and Zio XT ECG Monitoring System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Rooti Rx offers up to 7 days of continuous ECG and actigraphy recording. In contrast, the Zio XT system provides continuous ambulatory cardiac monitoring for up to 14 days.
Rooti Rx provides options for either single or three-channel ECG recording. The Zio XT ECG Monitoring System utilizes a single-lead ECG biosensor.
Rooti Rx is described as a compact, wearable ECG device. The Zio XT biosensor is a wearable single-lead ECG that is water-resistant for daily activities and features no external leads or wires for enhanced patient comfort and high compliance.
Rooti Rx uses AI-driven interpretation and quality assurance checks, with fast report generation within 24 hours. Zio XT employs a proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis and cloud-based reporting via its ZEUS platform.
Rooti Rx utilizes mobile telemetry cardiac tags for real-time event marking by patients. The Zio XT system includes a patient-activated button specifically for symptomatic event logging.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.